LifeMD, Inc. — Director's Dealing 2023

May 24, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2023-05-22

Reporting Person: Schreiber Justin (CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-22	Common Stock, par value $0.01	P	17664	$2.152	Acquired	2812284	Direct
2023-05-23	Common Stock, par value $0.01	P	32336	$2.06	Acquired	2844620	Direct

Footnotes

F1: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.13 to $2.16 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: Includes 2,794,620 shares previously reported as held indirectly which were distributed to the Reporting Person and are now held directly.

F3: The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $1.995 to $2.15 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.